Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer
Shawn M. Hillier, Kevin P. Maresca, Frank J. Femia, John C. Marquis, Catherine A. Foss, Nghi Nguyen, Craig N. Zimmerman, John A. Barrett, William C. Eckelman, Martin G. Pomper, John L. Joyal, John W. Babich
Dive into the research topics of 'Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer'. Together they form a unique fingerprint.